In that sense, the upcoming discovery of novel HACE1 mitochondrial targets will open an exciting scenario that will improve the knowledge about the physiopathology of SPPRS. The gene discussed is HACE1; the disease is spastic paraplegia-severe developmental delay-epilepsy syndrome.